Table 1.
Baseline Demographics and Clinical Characteristics of Patients with PTCL-NOS, AITL, and ALCL (N = 273)
| Characteristic | No. (%) |
|---|---|
| Age (years) | |
| Median | 63.1 |
| 65+ | 123 (45.1%) |
|
| |
| Sex | |
| Male | 181 (66.3) |
| Female | 92 (33.7) |
|
| |
| Race | |
| Black | 42 (15.4) |
| White | 211 (77.3) |
| Other | 13 (4.8) |
| Unknown | 7 (2.6) |
|
| |
| Ann Arbor Stage | |
| I | 29 (10.6) |
| II | 35 (12.8) |
| III | 82 (30.0) |
| IV | 127 (46.5) |
|
| |
| Any B-Symptoms present | 126 (46.2) |
|
| |
| Serum LDH elevated* | 118 (44.4) |
|
| |
| Histopathology | |
| PTCL-NOS | 140 (51.3) |
| AITL | 71 (26.0) |
| ALCL | 62 (22.7) |
| ALK− | 49 (79.0) |
| ALK+ (IPI 2–5) | 13 (21.0) |
|
| |
| Median IPI | 2 |
|
| |
| ECOG Performance Status | |
| 0–1 | 248 (90.8) |
| 2 | 23 (8.4) |
| ≥3 | 2 (0.7) |
|
| |
| Enrolling institution | |
| Academic | 236 (86.0) |
| Community | 37 (14.0) |
|
| |
| Clinical trial participant | 57 (20.9) |
Baseline information is missing for 2 patients.
Abbreviations: LDH, lactate dehydrogenase; IPI, International Prognostic Index; PTCL-NOS, peripheral T-cell lymphoma-not otherwise specified; ECOG, Eastern Cooperative Oncology Group
*
Information on LDH is missing for 7 patients.